News

  • Oct 23, 2007
    Stem Cell Innovations Cites Two Recent Government Documents Supporting the use of Cell-Based Assays for Toxicity Testing
  • June 25, 2007
    Stem Cell Innovations and High Q Foundation Collaborate to Develop Novel Models of Huntington's Disease
  • May 30, 2007
    Stem Cell Innovations and TNO to Collaborate on Generating PluriCell Derived Cartilage and Cardiomyocytes; Awarded Dutch EZ-Cofinancing Grant
  • May 7, 2007
    Stem Cell Innovations Signs Compound Validation Collaboration with H. Lundbeck A/S
  • April 10, 2007
    Stem Cell Innovations Patents on Pluripotent Cells Cited by the U.S. Patent and Trademark Office as Prior Art, Pre-Dating the WARF and Thomson Core Embryonic Stem Cell Patents
  • March 27, 2007
    Stem Cell Innovations To Validate Circomed's Cardiovascular Compounds Using Its C3A Human Liver Cell System
  • March 9, 2007
    Biotechnology Thought-Leader, David Perryman Presents at Acclaimed TED2007 Conference
  • March 5, 2007
    Stem Cell Innovations Names Ian Lyons, Ph.D., U.S. Chief Scientific Officer
  • February 13, 2007
    Stem Cell Innovations to Present Data at the Stem Cells World Congress That PluriCellsTM Can Produce Cells Important in Cardiovascular Disease
  • February 9, 2007
    Stem Cell Innovations Seeks European Union Registration for Its in vitro Toxicology Suite
  • January 9, 2007
    Stem Cell Innovations Announces Issuance of Fundamental Human Stem Cell Patent